The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterisation of the TCR repertoire in NSCLC to reveal the relationship between TCR heterogeneity and genetic heterogeneity that is influenced by mutational load and is associated with disease recurrence.
 
Kroopa Joshi
No Relationships to Disclose
 
Mazlina Ismail
No Relationships to Disclose
 
James L Reading
No Relationships to Disclose
 
Marc Robert De Massy
No Relationships to Disclose
 
Imran Uddin
No Relationships to Disclose
 
Mariam Jamal-Hanjani
Consulting or Advisory Role - Achilles Therapeutics
Patents, Royalties, Other Intellectual Property - Methods for lung cancer detection – patent number PCT/US2017/28013 (joint inventor). This patent encompasses the methods using ctDNA for detecting single nucleotide variants in lung cancer, especially stage 3a lung adenocarcinoma and lung squamous cell ca (Inst)
 
Selvaraju Veeriah
No Relationships to Disclose
 
Theres Oakes
No Relationships to Disclose
 
Yien Ning Sophia Wong
No Relationships to Disclose
 
Andrew James Scott Furness
No Relationships to Disclose
 
Ehsan Ghorani
No Relationships to Disclose
 
Andrew Georgiou
No Relationships to Disclose
 
Carmella Beastall
No Relationships to Disclose
 
Nagina Mangal
No Relationships to Disclose
 
Assma Ben Aissa
No Relationships to Disclose
 
Mariana Werner Sunderland
No Relationships to Disclose
 
Karl Peggs
No Relationships to Disclose
 
Charles Swanton
Stock and Other Ownership Interests - Achilles Therapeutics; Apogen Biotechnologies; Epic Sciences; GRAIL
Honoraria - Boehringer Ingelheim; Celgene; GlaxoSmithKline; Lilly; Ono Pharmaceutical; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Genentech/Roche
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Founder of Achilles Therapeutics: a biotechnology company funded by Syncona/Wellcome Trust to target clonal Neoantigens through vaccine and cell therapy approaches; Patent WO2016174085 A1: Method for treating cancer based on identification of clonal neo-antigens; Patent WO2017042394 A1 :Methods for identifying a subject with cancer who is suitable for treatment with an immune checkpoint intervention
 
Benjamin Chain
No Relationships to Disclose
 
Sergio A Quezada
No Relationships to Disclose